Glen Santangelo
Stock Analyst at Barclays
(2.26)
# 2,746
Out of 5,245 analysts
146
Total ratings
44%
Success rate
-3.32%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Maintains: Overweight | $36 → $25 | $19.57 | +27.75% | 2 | May 20, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintains: Overweight | $15 → $16 | $12.42 | +28.82% | 2 | May 20, 2026 | |
| VTRS Viatris | Maintains: Overweight | $17 → $22 | $16.65 | +32.13% | 7 | May 19, 2026 | |
| PGNY Progyny | Maintains: Overweight | $23 → $27 | $24.88 | +8.52% | 7 | May 18, 2026 | |
| PHR Phreesia | Downgrades: Equal-Weight | $24 → $10 | $8.92 | +12.11% | 4 | May 15, 2026 | |
| DOCS Doximity | Downgrades: Equal-Weight | $38 → $20 | $19.94 | +0.30% | 5 | May 15, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Overweight | $38 → $40 | $34.07 | +17.41% | 8 | May 6, 2026 | |
| CTEV Claritev | Initiates: Overweight | $28 | $21.67 | +29.21% | 1 | Apr 24, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $30 → $23 | $18.41 | +24.93% | 4 | Apr 8, 2026 | |
| PHAT Phathom Pharmaceuticals | Upgrades: Overweight | $16 → $18 | $11.33 | +58.87% | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8.5 → $7 | $6.57 | +6.54% | 9 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $27 → $25 | $23.35 | +7.07% | 7 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $4 | $3.34 | +19.76% | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $200 | $163.61 | +22.24% | 4 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $29 | $23.75 | +22.11% | 7 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5.5 → $5.25 | $5.20 | +0.96% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $7 | $5.47 | +27.97% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7.5 → $8 | $13.43 | -40.43% | 2 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $258 | $200.68 | +28.56% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $960 → $1,050 | $766.08 | +37.06% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $110 | $88.11 | +24.84% | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $425 | $274.91 | +54.60% | 2 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $34 | $23.43 | +45.11% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $559.37 | +43.02% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $2.64 | +4.17% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $37.01 | +35.10% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $34.07 | +64.37% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $81.32 | +67.24% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $6.19 | +45.40% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $62.26 | +60.62% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $74.21 | +15.89% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $21.73 | +38.06% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $10.21 | +17.53% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $82.72 | +20.89% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $35.26 | +38.97% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.06 | +1,550.17% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $76.73 | -28.32% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.60 | +681.25% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.29 | +2,078.99% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.96 | +1,407.54% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.8522 | +4,124.36% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $93.26 | - | 3 | Mar 17, 2021 |
Waystar Holding
May 20, 2026
Maintains: Overweight
Price Target: $36 → $25
Current: $19.57
Upside: +27.75%
Amneal Pharmaceuticals
May 20, 2026
Maintains: Overweight
Price Target: $15 → $16
Current: $12.42
Upside: +28.82%
Viatris
May 19, 2026
Maintains: Overweight
Price Target: $17 → $22
Current: $16.65
Upside: +32.13%
Progyny
May 18, 2026
Maintains: Overweight
Price Target: $23 → $27
Current: $24.88
Upside: +8.52%
Phreesia
May 15, 2026
Downgrades: Equal-Weight
Price Target: $24 → $10
Current: $8.92
Upside: +12.11%
Doximity
May 15, 2026
Downgrades: Equal-Weight
Price Target: $38 → $20
Current: $19.94
Upside: +0.30%
Teva Pharmaceutical Industries
May 6, 2026
Maintains: Overweight
Price Target: $38 → $40
Current: $34.07
Upside: +17.41%
Claritev
Apr 24, 2026
Initiates: Overweight
Price Target: $28
Current: $21.67
Upside: +29.21%
Amphastar Pharmaceuticals
Apr 8, 2026
Maintains: Equal-Weight
Price Target: $30 → $23
Current: $18.41
Upside: +24.93%
Phathom Pharmaceuticals
Mar 27, 2026
Upgrades: Overweight
Price Target: $16 → $18
Current: $11.33
Upside: +58.87%
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $8.5 → $7
Current: $6.57
Upside: +6.54%
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $27 → $25
Current: $23.35
Upside: +7.07%
Mar 24, 2026
Maintains: Underweight
Price Target: $5 → $4
Current: $3.34
Upside: +19.76%
Mar 17, 2026
Upgrades: Overweight
Price Target: $200
Current: $163.61
Upside: +22.24%
Mar 11, 2026
Maintains: Overweight
Price Target: $25 → $29
Current: $23.75
Upside: +22.11%
Mar 10, 2026
Maintains: Equal-Weight
Price Target: $5.5 → $5.25
Current: $5.20
Upside: +0.96%
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.47
Upside: +27.97%
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $13.43
Upside: -40.43%
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $200.68
Upside: +28.56%
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $766.08
Upside: +37.06%
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $88.11
Upside: +24.84%
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $274.91
Upside: +54.60%
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $23.43
Upside: +45.11%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $559.37
Upside: +43.02%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.64
Upside: +4.17%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $37.01
Upside: +35.10%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $34.07
Upside: +64.37%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $81.32
Upside: +67.24%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $6.19
Upside: +45.40%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $62.26
Upside: +60.62%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $74.21
Upside: +15.89%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $21.73
Upside: +38.06%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $10.21
Upside: +17.53%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $82.72
Upside: +20.89%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $35.26
Upside: +38.97%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $6.06
Upside: +1,550.17%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $76.73
Upside: -28.32%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.60
Upside: +681.25%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.29
Upside: +2,078.99%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.96
Upside: +1,407.54%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $0.8522
Upside: +4,124.36%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $93.26
Upside: -